Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared a post on LinkedIn:
“Thanks for the opportunity to share some thoughts at our ‘How Well Do You Know Your ADCs?’ session at WCLC25 on mechanistic and biological rationale behind toxicities associated with Antibody Drug Conjugates and how we can potentially improve upon our technology and patients selection to reduce toxicities and to improve the therapeutic index and efficacy in this class of agents.
A couple of key overview slides here to share with the community.
Thanks Alfredo Addeo, Francesco Cortiula, Rosalyn Juergens, Alessandra Curioni Fontecedro and Luis Leonardo Rojas Puentes and all the attendees who participated in the interactive quiz for an informative and fruitful session!”
More posts featuring Herbert Loong.
